Personalized Medicine in the Age of Pharmacoproteomics: A Close up on India and Need for Social Science Engagement for Responsible Innovation in Post-Proteomic Biology.
作者信息
Reddy Panga Jaipal, Jain Rekha, Paik Young-Ki, Downey Robin, Ptolemy Adam S, Ozdemir Vural, Srivastava Sanjeeva
机构信息
Wadhwani Research Center for Biosciences and Bioengineering, Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, India.
出版信息
Curr Pharmacogenomics Person Med. 2011 Mar 1;9(1):67-75. doi: 10.2174/187569211794728850.
Abstract
摘要
相似文献
1
Personalized Medicine in the Age of Pharmacoproteomics: A Close up on India and Need for Social Science Engagement for Responsible Innovation in Post-Proteomic Biology.
Curr Pharmacogenomics Person Med. 2011 Mar 1;9(1):67-75. doi: 10.2174/187569211794728850.
2
Role of pharmacoproteomics in the development of personalized medicine.
Pharmacogenomics. 2004 Apr;5(3):331-6. doi: 10.1517/phgs.5.3.331.29830.
3
Role of Proteomics in the Development of Personalized Medicine.
Adv Protein Chem Struct Biol. 2016;102:41-52. doi: 10.1016/bs.apcsb.2015.09.002. Epub 2015 Nov 11.
4
Opportunities for pharmacoproteomics in biomarker discovery.
Proteomics. 2023 Apr;23(7-8):e2200031. doi: 10.1002/pmic.202200031. Epub 2022 Sep 22.
5
Bernard Lerer: recipient of the 2014 inaugural Werner Kalow Responsible Innovation Prize in Global Omics and Personalized Medicine (Pacific Rim Association for Clinical Pharmacogenetics).
OMICS. 2014 Apr;18(4):211-21. doi: 10.1089/omi.2014.0029. Epub 2014 Mar 20.
6
Synthetic biology and the prospects for responsible innovation.
Essays Biochem. 2016 Nov 30;60(4):347-355. doi: 10.1042/EBC20160048.
8
Personalized Medicine Across Disciplines and without Borders. Vural Özdemir speaks to Hannah Wilson, Commissioning Editor.
Per Med. 2014;11(7):687-691. doi: 10.2217/pme.14.70.
9
Digging Deeper into Precision/Personalized Medicine: Cracking the Sugar Code, the Third Alphabet of Life, and Sociomateriality of the Cell.
OMICS. 2020 Feb;24(2):62-80. doi: 10.1089/omi.2019.0220. Epub 2020 Jan 28.
10
Pharmacoproteomics reveals energy metabolism pathways as therapeutic targets of ivermectin in ovarian cancer toward 3P medical approaches.
EPMA J. 2024 Nov 25;15(4):711-737. doi: 10.1007/s13167-024-00385-1. eCollection 2024 Dec.
引用本文的文献
1
"Omics"-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives.
Proteomes. 2016 Sep 12;4(3):28. doi: 10.3390/proteomes4030028.
2
Personalized Medicine in a New Genomic Era: Ethical and Legal Aspects.
Sci Eng Ethics. 2017 Aug;23(4):1207-1212. doi: 10.1007/s11948-016-9828-4. Epub 2016 Nov 28.
3
A Mobilising Concept? Unpacking Academic Representations of Responsible Research and Innovation.
Sci Eng Ethics. 2017 Feb;23(1):81-103. doi: 10.1007/s11948-016-9761-6. Epub 2016 Mar 8.
4
Ethical, Political and Societal Implications of the Open Access Journal Movement in the Era of Economic Crisis, with Emphasis on Public Health Pharmacogenomics.
Curr Pharmacogenomics Person Med. 2013 Dec;11(4):312-315. doi: 10.2174/1875692111666131126234122.
5
Public Health Pharmacogenomics and the Design Principles for Global Public Goods - Moving Genomics to Responsible Innovation.
Curr Pharmacogenomics Person Med. 2013 Mar 24;11(1):1-4. doi: 10.2174/1875692111311010001.
6
End of the Beginning and Public Health Pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine.
Curr Pharmacogenomics Person Med. 2012 Jan 1;10(1):1-6. doi: 10.2174/1875692111201010001.
7
Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA).
Curr Pharmacogenomics Person Med. 2011 Dec 1;9(4):243-251. doi: 10.2174/187569211798377153.
本文引用的文献
1
Realizing individualized medicine: the road to translating proteomics from the laboratory to the clinic.
Per Med. 2011 Jan;8(1):45-57. doi: 10.2217/pme.10.76.
2
Forward Look: Tenth Anniversary of the Human Genome Sequence and 21 Century Postgenomics Global Health - A Close Up on Africa and Women's Health.
Curr Pharmacogenomics Person Med. 2011 Sep 1;9(3):148-155. doi: 10.2174/187569211796957511.
3
Steering vaccinomics innovations with anticipatory governance and participatory foresight.
OMICS. 2011 Sep;15(9):637-46. doi: 10.1089/omi.2011.0087. Epub 2011 Aug 17.
4
SPIRE: Systematic protein investigative research environment.
J Proteomics. 2011 Dec 10;75(1):122-6. doi: 10.1016/j.jprot.2011.05.009. Epub 2011 May 13.
5
Pharmacoproteomic analysis of a novel cell-permeable peptide inhibitor of tumor-induced angiogenesis.
Mol Cell Proteomics. 2011 Aug;10(8):M110.005264. doi: 10.1074/mcp.M110.005264. Epub 2011 May 10.
6
The human proteome project: Current state and future direction.
Mol Cell Proteomics. 2011 Apr 29. doi: 10.1074/mcp.O111.009993.
7
Chronic Non-communicable Diseases as a Threat for All: Recent Global Initiatives.
Sultan Qaboos Univ Med J. 2010 Dec;10(3):306-9. Epub 2010 Nov 14.
8
Application of proteomics in asthma research.
Expert Rev Proteomics. 2011 Apr;8(2):221-30. doi: 10.1586/epr.11.4.
9
A comprehensive map of the human urinary proteome.
J Proteome Res. 2011 Jun 3;10(6):2734-43. doi: 10.1021/pr2003038. Epub 2011 May 9.
10
Asia-Pacific Health 2020 and Genomics without Borders: Co-Production of Knowledge by Science and Society Partnership for Global Personalized Medicine.
Curr Pharmacogenomics Person Med. 2011 Mar 1;9(1):1-5. doi: 10.2174/187569211794728841.
Zotero 插件